PHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Mar 2021
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2021 |
| Quarter | 1 Qtr |
| Quarterly report for the financial period ended | 31 Mar 2021 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Mar 2021
|
31 Mar 2020
|
31 Mar 2021
|
31 Mar 2020
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
793,499
|
819,921
|
793,499
|
819,921
|
| 2 | Profit/(loss) before tax |
31,524
|
30,880
|
31,524
|
30,880
|
| 3 | Profit/(loss) for the period |
22,828
|
22,415
|
22,828
|
22,415
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
23,136
|
22,399
|
23,136
|
22,399
|
| 5 | Basic earnings/(loss) per share (Subunit) |
8.84
|
8.57
|
8.84
|
8.57
|
| 6 | Proposed/Declared dividend per share (Subunit) |
4.00
|
6.00
|
4.00
|
6.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.3600
|
1.2900
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 21 May 2021 |
| Category | Financial Results |
| Reference Number | FRA-20052021-00011 |